About Euvipharm
Euvipharm is a Healthcare company based in Vietnam founded in 2005, and was acquired by JW Pharmaceutical in September 2019. Pharmaceutical ingredients and formulations are manufactured under contract. Its focus areas include Biopharma Outsourcing, CDMO and Small Molecules & Peptides.
Company details
Euvipharm was established in 2005 in Long An, Vietnam, within the pharmaceutical sector. Contract manufacturing services are provided for active pharmaceutical ingredients and finished formulations. Operations are centered on production processes that meet industry standards, supporting clients in developing and supplying medicinal products. The companys location facilitates regional distribution in Southeast Asia.
- Headquarters Long An, Vietnam
- Stage Acquired
- SectorsHealthcare
- Website euvipharm.com.vn
- Acquired by JW Pharmaceutical (Sep 2019)
- InvestorsBausch Health
& 2 more
- Acquired by
Investors in Euvipharm
Euvipharm has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Bausch Health, JW Pharmaceutical and Công ty CP Dược phẩm Cá»u Long.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Pharmaceutical products and medical devices are developed and manufactured. | 1945 | jw-pharma.co.kr | Seoul, South Korea | |
| pharimexco.com.vn | ||||
Therapeutics for multiple diseases including dermatology and neurology are developed. | 1960 | bauschhealth.com | Laval, Canada |
Investor details for Euvipharm
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Euvipharm
4 dated milestones of Euvipharm across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Euvipharm is founded.
- Exit Acquired by Bausch Health.
- Exit Acquired by Công ty CP Dược phẩm Cá»u Long.
- Exit Acquired by JW Pharmaceutical.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Euvipharm
Complete news archive for Euvipharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Euvipharm
Euvipharm was founded in 2005.
Euvipharm is headquartered in Vietnam. It is registered at Long An, Vietnam.
Euvipharm was established in 2005 in Long An, Vietnam, within the pharmaceutical sector. Contract manufacturing services are provided for active pharmaceutical ingredients and finished formulations. Operations are centered on production processes that meet industry standards, supporting clients in developing and supplying medicinal products. The companys location facilitates regional distribution in Southeast Asia.
Euvipharm has 3 investors. Key investors include Bausch Health, JW Pharmaceutical, and Công ty CP Dược phẩm Cá»u Long.
Yes. Euvipharm was acquired by JW Pharmaceutical in September 2019.

